Clinical Trial Update: NASHA/Dx as a Perianal Implant for the Treatment of Persistent Fecal Incontience After Anorectal Malformation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating NASHA/Dx as a perianal implant for persistent fecal incontinence following anorectal malformation has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anorectal Malformation
• Fecal Incontinence

Drugs mentioned

• NASHA/Dx

Snippet

Sponsor: Uppsala University | Conditions: Fecal Incontinence, Anorectal Malformation | Phase 4 | Status: COMPLETED